TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from ConvaTec ( (GB:CTEC) ) is now available.
ConvaTec Group PLC has executed a share buyback transaction, purchasing 284,667 ordinary shares as part of its $300 million share buyback program announced earlier in August 2025. The purchased shares will be held in treasury, and this move is expected to impact the company’s share capital structure, potentially enhancing shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £3.25 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
Spark’s Take on GB:CTEC Stock
According to Spark, TipRanks’ AI Analyst, GB:CTEC is a Outperform.
ConvaTec’s overall stock score is driven primarily by its strong financial performance, characterized by consistent revenue growth and solid profitability. Technical analysis indicates a moderate upward trend, although valuation metrics suggest the stock may be overvalued. The absence of earnings call insights and corporate events limits additional context.
To see Spark’s full report on GB:CTEC stock, click here.
More about ConvaTec
ConvaTec Group PLC operates in the medical products and technologies industry, focusing on providing advanced wound care, ostomy care, continence and critical care, and infusion care products. The company aims to improve the lives of patients by offering innovative solutions in these areas.
Average Trading Volume: 9,406,962
Technical Sentiment Signal: Hold
Current Market Cap: £4.61B
Find detailed analytics on CTEC stock on TipRanks’ Stock Analysis page.